Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Approves OraftiP95 In Infant Formulas - Nutraceuticals World

What are you searching for?

Sign in
Regulations

FDA Approves OraftiP95 In Infant Formulas

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

The U.S. Food and Drug Administration (FDA) has acknowledged that Pfizer Nutrition, Madison, NJ, and Belgium-based BENEO’s ingredient Orafti P95 is safe for addition to milk-based term infant formula powder. FDA agreed with the Generally Recognized as Safe (GRAS) determination jointly submitted by Pfizer Nutrition and BENEO in July 2011. Orafti P95, manufactured by BENEO, is a soluble dietary fiber, which is commonly referred to as oligofructose, a fructan derived from the chicory root plant. Ingestion of oligofructose can provide a prebiotic effect by selectively stimulating the growth of beneficial gut microflora. 

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics